Suchergebnisse - "Maccarrone, Mauro"

PubPharm (703)

1

An overview of retinal light damage models for preclinical studies on age-related macular degeneration : identifying molecular hallmarks and therapeutic targets

enthalten in: Reviews in the neurosciences | 2024

von Carozza, G. | Zerti, D. | Tisi, A. | +3

2

Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher Advanced Glycation End-products (AGEs) content and reduced bone strength

enthalten in: bioRxiv.org | 2024

von Leanza, G. | Cannata, F. | Faraj, M. | +15

3

Bone canonical Wnt signaling is downregulated in type 2 diabetes and associates with higher advanced glycation end-products (AGEs) content and reduced bone strength

enthalten in: eLife | 2024

von Leanza, G. | Cannata, F. | Faraj, M. | +15

4

Conformational Dynamics of Lipoxygenases and Their Interaction with Biological Membranes

enthalten in: International journal of molecular sciences | 2024

von Erba, F. | Mei, G. | Minicozzi, V. | +3

5

Visualization of membrane localization and functional state of CB2R pools by matched agonist and inverse agonist probe pairs

enthalten in: chemRxiv.org | 2024

von Wasinka-Kalwa, M. | Omran, A. | Mach, L. | +22

6

Simulated Microgravity Affects Pro-Resolving Properties of Primary Human Monocytes

enthalten in: Cells | 2024

von Leuti, A. | Fava, M. | Pellegrini, N. | +6

7

Bioactive signalling lipids as drivers of chronic liver diseases

enthalten in: Journal of hepatology | 2024

von Kaffe, E. | Tisi, A. | Magkrioti, C. | +4

8

An overview of retinal light damage models for preclinical studies on age-related macular degeneration: identifying molecular hallmarks and therapeutic targets

enthalten in: Reviews in the neurosciences | 2023

von Carozza, G. | Zerti, D. | Tisi, A. | +3

9

A game of networks : Do different lipids interact to orchestrate inflammatory homeostasis?

enthalten in: Cell chemical biology | 2023

von Leuti, A. | Fava, M. | Maccarrone, M.

CommentOn: Cell Chem Biol. 2023 Dec 21;30(12):1508-1524.e7. - PMID 37647900

10

Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2023

von Criscuolo, E. | De Sciscio, M. | De Cristofaro, A. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[71]